Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Synjardy Side Effects Center
Medically reviewed by Min Clinic Staff | Updated: January 2026
- Generic Name: empagliflozin and metformin hydrochloride tablets
- Brand Name: Synjardy
Synjardy (Empagliflozin and Metformin Hydrochloride Tablets) side effects drug center
Synjardy Side Effects Center
What Is Synjardy?
Synjardy (empagliflozin and metformin hydrochloride) is a combination of a sodium-glucose co-transporter 2 (SGLT2) inhibitor and a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are not adequately controlled on a regimen containing empagliflozin or metformin, or in patients already being treated with both empagliflozin and metformin. Synjardy is not for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
What Are Side Effects of Synjardy?
Common side effects of Synjardy include:
- low blood sugar (hypoglycemia),
- urinary tract infection,
- increased urination,
- genital yeast infections,
- diarrhea,
- nausea,
- Contact
- Location map
- For professionals
